echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The BMS-Pfizer Alliance lawsuit wins!

    The BMS-Pfizer Alliance lawsuit wins!

    • Last Update: 2021-09-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Bristol-Myers Squibb (BMS)-Pfizer Alliance recently issued a statement that the U.


    According to the CAFC's ruling, the earliest time for a generic drug manufacturer to be allowed to launch its apixaban generic drug product is April 1, 2028, but this may depend on additional litigation and challenges


    Eliquis is an oral anticoagulant discovered by BMS


    Eliquis was approved for listing in the European Union and the United States in May 2011 and December 2012, respectively, and entered the Chinese market in January 2013


    In the more than ten years since its launch, Eliquis has grown into a star product of BMS and Pfizer


    Over the years, BMS and Pfizer have also been working hard to fight against generic drug manufacturers


    BMS and Pfizer eventually reached a legal settlement with several of their competitors, including Mylan (now Huizhi) and Micro Labs.


    The CAFC ruling is a good thing for the BMS-Pfizer alliance


    Reference source:

    Reference source:

    1.


    1.


    2.
    Inventory of TOP15 drugs with patent expiration in the next ten years involves AbbVie, Merck, Pfizer, etc.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.